ArgPure DEAE Agarose Fast Flow
ARG Biotech (Noavaran Zist Gostar ARG Co.) is proud to present ArgPure DEAE Agarose Fast Flow (DEAE-S56) , a high-performance weak anion exchange chromatography resin developed to meet the demanding requirements of modern biopharmaceutical downstream processing. Designed for reliable protein purification, this chromatography medium combines excellent binding performance, chemical stability, and process robustness to support both research and industrial-scale manufacturing.
A Proven Solution for Downstream Processing
ArgPure DEAE Agarose Fast Flow is composed of cross-linked 6% agarose beads functionalized with diethylaminoethyl (DEAE) groups, creating a highly efficient weak anion exchanger for the purification of proteins, enzymes, vaccines, and other biological molecules. The hydrophilic agarose matrix in DEAE Agarose minimizes non-specific interactions, resulting in improved product purity and reduced host-cell-derived impurities.
Widely applicable for both capture and intermediate purification steps, ArgPure DEAE Agarose supports the purification workflows of a broad range of approved biopharmaceutical products. Its high chemical stability enables validated Cleaning-in-Place (CIP) and sanitization procedures, helping manufacturers maintain process consistency while reducing operational costs.
Key Technical Advantages
ArgPure DEAE Agarose Fast Flow offers a combination of performance and operational flexibility, including:
* Weak anion exchange functionality based on DEAE ligand chemistry.
* Cross-linked spherical agarose matrix with excellent flow properties.
* Operational pH stability range of 2–12 and CIP stability range of 2–14.
* High ionic capacity of **0.12–0.14 mmol Cl⁻/mL resin.
* Dynamic binding capacity reaching approximately 80–110 mg BSA/mL resin.
* Compatibility with common process chemicals, including M NaOH, 2 M NaCl, and 30–50% ethanol solutions.
Designed for Long-Term Process Reliability
To evaluate resin durability, ARG Biotech conducted a comprehensive lifetime assessment involving 100 purification and cleaning cycles. Throughout the study, DEAE Agarose demonstrated stable chromatographic performance following repeated protein loading, elution, and CIP treatment using sodium hydroxide. These results highlight the resin’s suitability for routine industrial operations where reproducibility and longevity are critical performance indicators.
Supporting the Growth of the Biopharmaceutical Industry
As global demand for biologics continues to increase, the need for reliable, high-capacity purification technologies becomes more important than ever. DEAE Agarose Fast Flow has been developed to provide biopharmaceutical manufacturers with a dependable chromatography solution that delivers process efficiency, product quality, and regulatory confidence. The resin fulfills industrial requirements for robust performance, supply security, and scalable purification workflows.
Through the development of the ArgPure chromatography resin portfolio, ARG Biotech continues to expand its capabilities in supplying purification solutions for the biotechnology and biopharmaceutical industries, with a focus on consistent performance, technical support, and the evolving needs of modern downstream processing.
For more information about ArgPure chromatography resins and purification solutions, visit www.noavaranzist.com
